TFS CAPITAL LLC - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 92 filers reported holding PARATEK PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.94 and the average weighting 0.7%.

Quarter-by-quarter ownership
TFS CAPITAL LLC ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2016$272,000
-60.1%
19,531
-56.5%
0.05%
-49.0%
Q1 2016$681,000
+10.4%
44,891
+87.4%
0.10%
+63.3%
Q2 2015$617,000
+9.4%
23,960
+32.8%
0.06%
+9.1%
Q1 2015$564,00018,0430.06%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,609,398$7,821,0001.64%
Telemetry Investments, L.L.C. 242,514$1,179,0001.59%
Omega Fund Management, LLC 2,606,809$12,669,0001.42%
Bruce & Co., Inc. 1,343,312$6,528,0001.39%
1492 Capital Management LLC 488,309$2,373,0001.20%
Abingworth LLP 1,041,131$5,060,0001.15%
Trellus Management Company, LLC 295,000$1,434,0001.04%
Worth Venture Partners, LLC 389,440$1,893,0000.85%
CM Management, LLC 200,000$972,0000.72%
GENERAL AMERICAN INVESTORS CO INC 1,112,658$5,408,0000.46%
View complete list of PARATEK PHARMACEUTICALS INC shareholders